Tecogen (TGEN) Registration Filing summary

Use of proceeds and capital allocation

• Estimated offering expenses (excluding underwriting discounts/commissions) total $217,021, including SEC, NYSE, FINRA fees, accounting, legal, and printing costs.

Risk factors and disclosures

• Charter eliminates director liability for monetary damages except for breaches of loyalty, bad faith, unlawful acts, or improper personal benefit.

• Indemnification for directors/officers is provided to the fullest extent permitted by Delaware law, with advancement of expenses and insurance coverage up to $10 million.

• SEC notes indemnification for Securities Act liabilities is unenforceable as against public policy.

Management team and governance

• Principal executive, financial, and accounting officers are Abinand Rangesh (CEO/CFO) and Roger P. Deschenes (Chief Accounting Officer).

• Board includes Angelina M. Galiteva (Chairperson), John N. Hatsopoulos (Lead Director), Ahmed F. Ghoniem, Earl R. Lewis III, Susan F. Hirsch, and John M. Albertine.